Alternatives to ChemoCentryx

A global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases.

Biopharmaceutical company focused on developing and commercializing innovative medicines.

A global research-based biopharmaceutical company focused on developing advanced therapies for complex medical conditions.

A global oncology company developing and commercializing innovative cancer treatments.

Developing engineered biologics to harness the immune system for disease treatment.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biotechnology company developing novel immunotherapies for cancer.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.

Develops novel therapeutic antibodies for oncology and autoimmune diseases.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.